Stefan Constantin Ionel 4
4 · Amprius Technologies, Inc. · Filed Jan 30, 2026
Research Summary
AI-generated summary of this filing
Amprius (AMPX) CTO Stefan Ionel Sells Shares, Exercises Options
What Happened
- Stefan Constantin Ionel, Chief Technology Officer of Amprius Technologies (AMPX), exercised stock-derived awards and sold shares on January 28, 2026. He exercised 39,690 option/derivative shares (reported as 39,600 at $0.05 and 90 at $0.62) for a total exercise cost of $2,036, then sold 39,690 shares in open-market transactions for an aggregate proceeds of approximately $476,351 (average execution price reported as $12.00; range $12.00–$12.02). The filing also shows derivative disposition entries at $0.00, reflecting the conversion/settlement of those derivatives.
Key Details
- Transaction date: 2026-01-28; Form 4 filed 2026-01-30 (timely).
- Exercises/acquisitions: 90 shares @ $0.62 (≈ $56) and 39,600 shares @ $0.05 (≈ $1,980).
- Sale: 39,690 shares sold at an average price of $12.00 for total proceeds ≈ $476,351 (prices ranged $12.00–$12.02; F3).
- Footnote: Transactions were effected pursuant to a Rule 10b5-1 trading plan adopted Sept 11, 2025 (F1).
- Holdings after transaction: Not fully specified in the provided filing; filing notes 585,697 restricted stock units (RSUs) outstanding for the reporting person (F2).
- Derivative entries at $0.00 represent conversion/settlement of the exercised derivatives (reported as M-type transactions).
Context
- This was an exercise-plus-sale (cashless-style) event executed under a pre-established 10b5-1 plan, which is a routine way insiders systematically sell shares. The small out-of-pocket exercise cost ($2,036) and immediate sale produced the net proceeds ($476k). These filings are factual disclosures and do not, by themselves, indicate insider sentiment beyond the recorded transactions.
Insider Transaction Report
Form 4
Stefan Constantin Ionel
Chief Technology Officer
Transactions
- Exercise/Conversion
Common stock
[F1][F2]2026-01-28$0.62/sh+90$56→ 748,786 total - Exercise/Conversion
Common stock
[F1][F2]2026-01-28$0.05/sh+39,600$1,980→ 788,386 total - Sale
Common stock
[F1][F3][F2]2026-01-28$12.00/sh−39,690$476,351→ 748,696 total - Exercise/Conversion
Stock Option (right to buy)
[F1]2026-01-28−90→ 0 totalExercise: $0.62From: 2024-10-23Exp: 2027-03-15→ Common stock (90 underlying) - Exercise/Conversion
Stock Option (right to buy)
[F1]2026-01-28−39,600→ 0 totalExercise: $0.05From: 2022-09-14Exp: 2027-03-15→ Common stock (39,600 underlying)
Footnotes (3)
- [F1]The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2025.
- [F2]Includes 585,697 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock, subject to the applicable vesting schedule and conditions of each restricted stock unit.
- [F3]The price reported in Column 4 is an average execution price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.02, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Signature
/s/ Ricardo C. Rodriguez, attorney-in-fact on behalf of Constantin Ionel Stefan|2026-01-30